Categories
Announcements Find Funding Large Grant Opportunities

Research Matters

NIH: Drug Development Collaboratory (UG3/UH3 Clinical Trial Required)

The purpose of this FOA is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch and extramural researchers, for therapeutic development of small molecules, biologics, or gene therapies.

The purpose of this FOA is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch (TDB) and extramural researchers, for therapeutic development of small molecules, biologics, or gene therapies. The goal of any collaboration with TDB is to enable an Investigational New Drug application by the end of the UG3 phase.